STEMPOINT CAPITAL LP Hedge Fund

CIK: 0001952142 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $313,701 (100.0% shares, 0.0% debt)

Holdings (61)

ROIV ROIVANT SCIENCES LTD 8.3%
Value ($000) $26,021 Shares 2,578,860 Est. Cost $10.18 Unrealized +6.3%
SNDX SYNDAX PHARMACEUTICALS INC 6.3%
Value ($000) $19,639 Shares 1,598,594 Est. Cost $17.25 Unrealized -18.3%
SRRK SCHOLAR ROCK HLDG CORP 5.8%
Value ($000) $18,204 Shares 566,212 Est. Cost $36.74 Unrealized +4.7%
ACLX ARCELLX INC 5.7%
Value ($000) $17,960 Shares 273,774 Est. Cost $67.74 Unrealized 0.0%
MERUS N V 4.7%
Value ($000) $14,595 Shares 346,756 Est. Cost $39.75 Unrealized
IMVT IMMUNOVANT INC 4.6%
Value ($000) $14,586 Shares 853,472 Est. Cost $31.46 Unrealized -33.5%
MDGL MADRIGAL PHARMACEUTICALS INC 4.3%
Value ($000) $13,559 Shares 40,936 Est. Cost $328.59 Unrealized 0.0%
NUVL NUVALENT INC 4.3%
Value ($000) $13,503 Shares 190,401 Est. Cost $89.78 Unrealized -12.9%
RVMD REVOLUTION MEDICINES INC 3.6%
Value ($000) $11,272 Shares 318,782 Est. Cost $46.22 Unrealized -12.2%
JANX JANUX THERAPEUTICS INC 2.9%
Value ($000) $9,236 Shares 342,062 Est. Cost $39.68 Unrealized -5.0%
XENE XENON PHARMACEUTICALS INC 2.9%
Value ($000) $9,214 Shares 274,633 Est. Cost $41.35 Unrealized -8.2%
DNLI DENALI THERAPEUTICS INC 2.9%
Value ($000) $9,069 Shares 667,078 Est. Cost $22.35 Unrealized -14.3%
CNTA CENTESSA PHARMACEUTICALS PLC 2.7%
Value ($000) $8,532 Shares 593,335 Est. Cost $16.65 Unrealized
QURE UNIQURE NV 2.5%
Value ($000) $7,749 Shares 731,039 Est. Cost $13.36 Unrealized +5.0%
BBIO BRIDGEBIO PHARMA INC 2.3%
Value ($000) $7,206 Shares 208,437 Est. Cost $33.72 Unrealized 0.0%
CGON CG ONCOLOGY INC 2.3%
Value ($000) $7,102 Shares 289,823 Est. Cost $28.13 Unrealized 0.0%
SPRINGWORKS THERAPEUTICS INC 2.2%
Value ($000) $7,030 Shares 159,305 Est. Cost $44.13 Unrealized
ARQT ARCUTIS BIOTHERAPEUTICS INC 2.2%
Value ($000) $6,883 Shares 440,073 Est. Cost $5.99 Unrealized +135.3%
INSM INSMED INC 2.1%
Value ($000) $6,642 Shares 87,059 Est. Cost $72.02 Unrealized +6.2%
ALKS ALKERMES PLC 2.0%
Value ($000) $6,351 Shares 192,352 Est. Cost $28.50 Unrealized +14.4%
AKERO THERAPEUTICS INC 2.0%
Value ($000) $6,322 Shares 156,185 Est. Cost $40.48 Unrealized
BHVN BIOHAVEN LTD 1.9%
Value ($000) $6,024 Shares 250,564 Est. Cost $36.20 Unrealized -2.6%
CYTK CYTOKINETICS INC 1.9%
Value ($000) $6,014 Shares 149,648 Est. Cost $49.66 Unrealized -7.5%
BLUEPRINT MEDICINES CORP 1.7%
Value ($000) $5,481 Shares 61,927 Est. Cost $88.51 Unrealized
VTGN VISTAGEN THERAPEUTICS INC 1.6%
Value ($000) $5,112 Shares 2,366,554 Est. Cost $3.60 Unrealized -21.3%
TARA PROTARA THERAPEUTICS INC 1.6%
Value ($000) $5,072 Shares 1,190,579 Est. Cost $4.05 Unrealized +10.3%
KALV KALVISTA PHARMACEUTICALS INC 1.4%
Value ($000) $4,464 Shares 386,837 Est. Cost $10.36 Unrealized -1.5%
EWTX EDGEWISE THERAPEUTICS INC 1.3%
Value ($000) $3,966 Shares 180,255 Est. Cost $28.77 Unrealized -8.8%
SRZN SURROZEN INC 0.9%
Value ($000) $2,808 Shares 240,826 Est. Cost $10.29 Unrealized +12.9%
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value ($000) $2,381 Shares 49,241 Est. Cost $43.60 Unrealized -3.9%
ELVN ENLIVEN THERAPEUTICS INC 0.8%
Value ($000) $2,370 Shares 120,430 Est. Cost $25.06 Unrealized -14.1%
NBIX NEUROCRINE BIOSCIENCES INC 0.7%
Value ($000) $2,328 Shares 21,052 Est. Cost $126.68 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S 0.7%
Value ($000) $2,296 Shares 14,732 Est. Cost $155.86 Unrealized
BBOT HELIX ACQUISITION CORP II 0.7%
Value ($000) $2,270 Shares 200,900 Est. Cost $10.35 Unrealized +3.8%
SYRE SPYRE THERAPEUTICS INC 0.7%
Value ($000) $2,197 Shares 136,139 Est. Cost $20.81 Unrealized 0.0%
FOLD AMICUS THERAPEUTICS INC 0.7%
Value ($000) $2,194 Shares 268,919 Est. Cost $9.25 Unrealized 0.0%
NAMS NEWAMSTERDAM PHARMA COMPANY 0.7%
Value ($000) $2,141 Shares 104,585 Est. Cost $22.23 Unrealized 0.0%
RYTM RHYTHM PHARMACEUTICALS INC 0.6%
Value ($000) $1,791 Shares 33,816 Est. Cost $53.78 Unrealized +3.2%
ABUS ARBUTUS BIOPHARMA CORP 0.5%
Value ($000) $1,633 Shares 467,882 Est. Cost $3.33 Unrealized 0.0%
PCSC PERCEPTIVE CAP SOLUTIONS COR 0.5%
Value ($000) $1,545 Shares 150,000 Est. Cost $10.07 Unrealized +1.8%
GERN GERON CORP 0.5%
Value ($000) $1,527 Shares 960,307 Est. Cost $2.44 Unrealized 0.0%
IDYA IDEAYA BIOSCIENCES INC 0.3%
Value ($000) $1,097 Shares 66,999 Est. Cost $21.31 Unrealized 0.0%
ZLAB ZAI LAB LTD 0.3%
Value ($000) $955 Shares 26,421 Est. Cost $36.14 Unrealized
OCUL OCULAR THERAPEUTIX INC 0.3%
Value ($000) $913 Shares 124,523 Est. Cost $7.69 Unrealized 0.0%
DYN DYNE THERAPEUTICS INC 0.3%
Value ($000) $883 Shares 84,430 Est. Cost $14.30 Unrealized 0.0%
SLNO SOLENO THERAPEUTICS INC 0.3%
Value ($000) $797 Shares 11,155 Est. Cost $48.69 Unrealized 0.0%
IFRX INFLARX NV 0.2%
Value ($000) $740 Shares 725,019 Est. Cost $1.89 Unrealized 0.0%
SLDB SOLID BIOSCIENCES INC 0.2%
Value ($000) $733 Shares 198,150 Est. Cost $4.28 Unrealized 0.0%
WVE WAVE LIFE SCIENCES LTD 0.2%
Value ($000) $726 Shares 89,833 Est. Cost $10.28 Unrealized +6.4%
MBX MBX BIOSCIENCES INC 0.2%
Value ($000) $713 Shares 96,615 Est. Cost $10.57 Unrealized 0.0%
SION SIONNA THERAPEUTICS INC 0.2%
Value ($000) $628 Shares 60,000 Est. Cost $16.34 Unrealized 0.0%
BCAX BICARA THERAPEUTICS INC 0.2%
Value ($000) $613 Shares 47,078 Est. Cost $13.28 Unrealized 0.0%
EWTX EDGEWISE THERAPEUTICS INC 0.1%
Value ($000) $238 Shares 50,000 Est. Cost $28.77 Unrealized -8.8%
CVS CVS HEALTH CORP 0.1%
Value ($000) $165 Shares 64,100 Est. Cost Unrealized
MLYS MINERALYS THERAPEUTICS INC 0.0%
Value ($000) $94 Shares 125,000 Est. Cost $13.08 Unrealized -12.0%
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.0%
Value ($000) $43 Shares 100,000 Est. Cost $5.99 Unrealized +135.3%
KALV KALVISTA PHARMACEUTICALS INC 0.0%
Value ($000) $33 Shares 100,000 Est. Cost $10.36 Unrealized -1.5%
BBC ETFIS SER TR I 0.0%
Value ($000) $17 Shares 132,500 Est. Cost Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 0.0%
Value ($000) $16 Shares 10,000 Est. Cost $53.78 Unrealized +3.2%
MRK MERCK & CO INC 0.0%
Value ($000) $8 Shares 151,700 Est. Cost Unrealized
NVO NOVO-NORDISK A S 0.0%
Value ($000) $4 Shares 151,700 Est. Cost Unrealized